BlueRock Therapeutics Medical Hub

Welcome to the Medical Affairs Hub where you can access peer-reviewed manuscripts, posters, presentations, and abstracts from BlueRock Therapeutics' pioneering research in cell therapy.

Resources

Browse our medical resource library related to cell therapy

Contact

Connect with Medical Affairs for scientific inquiries

Featured Resources

Manuscript

Published in Nature

2025

Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease

V. Tabar, H. Sarva, A. M. Lozano, A. Fasano, S. K. Kalia, K. K. H. Yu, C. Brennan, Y. Ma, S. Peng, D. Eidelberg, M. Tomishima, S. Irion, W. Stemple, N. Abid, A. Lampron, L. Studer and C. Henchcliffe

View More Visit Resource

Poster

Presented at MDS

2025

Continued Evaluation of Bemdaneprocel Following a Phase 1 Study for Parkinson’s Disease: Outcomes Through 3 Years

Harini Sarva, MD; Claire Henchcliffe, MD, DPhil; Andres Lozano, MD, PhD; Alfonso Fasano, MD, PhD; Suneil Kalia, MD, PhD, FAANS, FRCSC; Kenny Kwok Hei Yu, MBBS, PhD, FRCS; Cameron Brennan, MD; Melinda Louie-Gao, PhD; Nicole Floro, MS; Nauman Abid, MD; Viviane Tabar, MD

View More Download PDF

Poster

Presented at PSG

2025

exPDite-2: A Phase 3, Randomized, Sham-Controlled, Double-Blind Trial to Evaluate Bemdaneprocel, a Midbrain Dopaminergic Neuron Progenitor Cell Therapy for Parkinson’s Disease

Nauman Abid, MD; Mathews Adera, MD; Melinda Louie-Gao, PhD; Gabriel Belfort, MD, PhD

View More Download PDF

Explore Further

Access the full library of manuscripts, posters, presentations, and abstracts related to our work in cell therapy.

View All Resources